FeraSpin Series XS-XXL

FeraSpin Series XS-XXL

The FeraSpin Series is derived from FeraSpin R contrast agents, is a product family of six size-selected iron oxide particles with well-defined particle sizes from 10 to 100 nm. Their identical chemical composition and ultra-narrow size distribution allow for fine-tuning of the pharmacologic profile according to specific applications. FeraSpin nanoparticles are well suited for sequence development, MR physics and nanoparticle physiology studies.
The FeraSpin Series comprises six superparamagnetic iron oxide (SPIO) and undltrasmall (USPIO) particles specifically formulated for pre-clinical magnetic resonance imaging (MRI): FeraSpin XS, FeraSpin S, FeraSpin M, FeraSpin L, FeraSpin XL, and FeraSpin XXL. Their well-defined sizes allow for MRI studies that rely on specific particle sizes.
FeraSpin XS to XXL are agents of high relaxivity and enhance the contrast in T1- as well as T2- and T2*-weighted MRI. The T2 effect increases with increasing particle size whereas the T1 effect increases with decreasing particle size. Upon accumulation in cells, the T1 effect diminishes and the T2 effect increases.
Upon intravenous injection, all agents of this series circulate in the bloodstream and are taken up by macrophages. They accumulate in the liver and spleen and are degraded within a few days. The iron is transferred into the physiological iron stores.
Uptake by macrophages depends on the particle size. Uptake by the Kupffer cells (macrophages of the liver) increases with particle size, thus leading to rapid accumulation in the liver and spleen and a short blood circulation time. With decreasing particle size, the uptake by the Kupffer cells is reduced, leading to a prolonged circulation time and increased uptake by other macrophages.
FeraSpin XS shows the longest blood circulation time among the FeraSpin products and therefore is particularly suited for vascular studies. This USPIO particle has the highest T1 effect and is specifically formulated for magnetic resonance angiography (MRA).
  • Selected references

    1. Lohrke, J. et al. (2008) Characterization of superparamagnetic iron oxide nanoparticles by asymmetrical flow-field-flow-fractionation. Nanomedicine 3: 437-452
    2. Allkemper, T. et al. (2002) Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. J. Immunother. 223: 432-438
    3. Tsuda, N. et al. (2005) Potential of superparamagnetic iron oxide in the differential diagnosis of metastasis and inflammation in bone marrow: experimental study. Invest. Radiol. 40: 676-681
    4. Metz, S. et al. (2004) Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur. Radiol. 14: 1851-1858
Product options: 12
130-095-140

FeraSpin XS

for 5
injections
(1)
EUR 480,00 
130-095-141

FeraSpin XS

for 5×5
injections
(1)
EUR 2.280,00 
130-095-166

FeraSpin S

for 5
injections
(1)
EUR 480,00 
130-095-167

FeraSpin S

for 5×5
injections
(1)
EUR 2.280,00 
130-095-168

FeraSpin M

for 5
injections
(1)
EUR 480,00 
130-095-169

FeraSpin M

for 5×5
injections
(1)
EUR 2.280,00 
130-095-170

FeraSpin L

for 5
injections
(1)
EUR 480,00 
130-095-171

FeraSpin L

for 5×5
injections
(1)
EUR 2.280,00 
130-095-172

FeraSpin XL

for 5
injections
(1)
EUR 480,00 
130-095-173

FeraSpin XL

for 5×5
injections
(1)
EUR 2.280,00 
130-095-174

FeraSpin XXL

for 5
injections
(1)
EUR 480,00 
130-095-175

FeraSpin XXL

for 5×5
injections
(1)
EUR 2.280,00 

Related products

1 products available